cobas LIAT Analyzer
Total Payments
$2.5M
Transactions
257
Doctors
0
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $338,201 | 96 | 0 |
| 2022 | $2.1M | 157 | 0 |
| 2021 | $98,290 | 4 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.5M | 257 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RD006250 | ROCHE MOLECULAR SYSTEMS, INC. | $2.1M | 0 |
| RD006702 | ROCHE MOLECULAR SYSTEMS, INC. | $327,627 | 0 |
| RD005881 | ROCHE MOLECULAR SYSTEMS, INC. | $87,382 | 0 |
| RD005524 | Roche Molecular Systems, Inc. | $16,246 | 0 |
Top Doctors Receiving Payments for cobas LIAT Analyzer
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Sacramento, CA | $2.5M | 257 |
Ad
Manufacturing Companies
- ROCHE MOLECULAR SYSTEMS, INC. $2.5M
- Roche Molecular Systems, Inc. $16,246
Product Information
- Type Device
- Total Payments $2.5M
- Total Doctors 0
- Transactions 257
About cobas LIAT Analyzer
cobas LIAT Analyzer is a device associated with $2.5M in payments to 0 healthcare providers, recorded across 257 transactions in the CMS Open Payments database. The primary manufacturer is ROCHE MOLECULAR SYSTEMS, INC..
Payment data is available from 2021 to 2023. In 2023, $338,201 was paid across 96 transactions to 0 doctors.
The most common payment nature for cobas LIAT Analyzer is "Unspecified" ($2.5M, 100.0% of total).
cobas LIAT Analyzer is associated with 4 research studies, including "RD006250" ($2.1M).